BenevolentAI Investor Conference Presentation Deck slide image

BenevolentAI Investor Conference Presentation Deck

BenevolentAl technology approach Our data foundations integrate the world's relevant and available biomedical data to surface insights through our tools, improving how scientists discover and develop new therapies 'Omics Molecules Experimental Data Literature Pathology Biological Systems 85+ Data Sources 46% information proprietary 1. Creating Data Foundations Integrated knowledge platform built to ingest, represent, and surface insights from large volumes of diverse data types Predictive algorithms Triage Evaluation Rii Hypothesis- Driven Target ID <<<<<< Progressibility Assessment <<<< Experimental validation 2. Al Tools for Scientists Suite of Al-driven tools and workflows allow scientists to explore data and discover novel, high-quality targets Portfolio Programmes Benevolent 7
View entire presentation